EGFR and neoplasm: Here we report that GLDC is polyubiquitinated at K636 following EGFR activation, which drives GLDC-dependent transcriptional inhibition of MHC-I genes and induces tumor cells to evade CD8<sup>+</sup> T cell-mediated immunosurveillance.